CONTINGENCIES

3 Months Ended

Sep. 30, 2016

Commitments and Contingencies Disclosure [Abstract]

CONTINGENCIES

NOTE G - CONTINGENCIES

The Company was able to close three open recalls with the FDA and is currently involved with one open voluntary product recall initiated May 20, 2016. Total recall costs incurred with the sole remaining open recall through September 30, 2016 were $3,197, of which $3,197 occurred in the quarter ending September 30, 2016. Future recall costs are not expected.